Consolidation ALK Tyrosine Kinase Inhibitors versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK+ Non-Small Cell Lung Cancer
Related Posts
Shimoda T, Ueyama H, Miyamoto Y, Watanabe A, Gotanda H, Kolte D, Latib A, Kaneko T, Zajarias A, Elmariah S, Takayama H, Tsugawa Y, Kuno[...]
Burley N, Lee Y, Liu L, Gangi A, Nasseri Y, Atkins K, Zaghiyan K, Murrell Z, Osipov A, Hendifar A, Hitchins M, Gong J. ctDNA-guided[...]
Hwang MC, Doughem K, Lee M, Gensler LS, Ishimori ML, Ward MM, Brown MA, Tahanan A, Weisman MH, Rahbar MH, Reveille JD. Radiographic Axial Spondyloarthritis[...]